Home LiteratureArticle Details
PMID: 21573172 Published · epublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Increased basal activity is a key determinant in the severity of human skeletal dysplasia caused by TRPV4 mutations.

PloS one ·Vol. 6 ·No. 5 ·2011-05-05 ·Pages e19533

Loukin S, Su Z, Kung C

Abstract

TRPV4 is a mechanically activated Ca(2+)-passing channel implicated in the sensing of forces, including those acting on bones. To date, 33 mutations are known to affect human bone development to different extents. The spectrum of these skeletal dysplasias (SD) ranges from dominantly inherited mild brachylomia (BO) to neonatal lethal forms of metatropic dysplasia (MD). Complexities of the results from fluorescence and electrophysiological studies have led to questions on whether channel activity is a good predictor of disease severity. Here we report on a systematic examination of 14 TRPV4 mutant alleles covering the entire SD spectrum. Expressed in Xenopus oocyte and without any stimulation, the wild-type channel had a ~1% open probability (Po) while those of most of the lethal MD channels approached 100%. All mutant channels had higher basal open probabilities, which limited their further increase by agonist or hypotonicity. The magnitude of this limitation revealed a clear correlation between the degree of over-activity (the molecular phenotype) and the severity of the disease over the entire spectrum (the biological phenotype). Thus, while other factors are at play, our results are consistent with the increased TRPV4 basal activity being a critical determinant of the severity of skeletal dysplasia. We discuss how the channel over-activity may lead to the "gain-of-function" phenotype and speculate that the function of wild-type TRPV4 may be secondary in normal bone development but crucial in an acute process such as fracture repair in the adult.

MeSH Terms
Animals Humans Oocytes Osteochondrodysplasias/etiology,genetics,metabolism,pathology Patch-Clamp Techniques TRPV Cation Channels/genetics,metabolism Xenopus laevis
Chemicals
TRPV Cation Channels TRPV4 protein, human
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Loukin Stephen
Laboratory of Molecular Biology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Su Zhenwei
Kung Ching
References (52)
52 references, click to expand
  1. OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity.
    Nat Cell Biol. 2000 Oct;2(10):695-702 PMID: 11025659
  2. TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts.
    Cell Metab. 2008 Sep;8(3):257-65 PMID: 18762026
  3. Metatropic dysplasia: clinical and radiographic findings in 11 patients demonstrating long-term natural history.
    Am J Med Genet A. 2007 Nov 1;143A(21):2512-22 PMID: 17879966
  4. Kozlowski type spondylometaphyseal dysplasia: a case report with literature review.
    Diagn Interv Radiol. 2006 Jun;12(2):70-3 PMID: 16752352
  5. Novel mechanism of massive photoreceptor degeneration caused by mutations in the trp gene of Drosophila.
    J Neurosci. 2000 Jan 15;20(2):649-59 PMID: 10632594
  6. Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss.
    J Cell Physiol. 2008 Jul;216(1):47-53 PMID: 18264976
  7. Temperature-modulated diversity of TRPV4 channel gating: activation by physical stresses and phorbol ester derivatives through protein kinase C-dependent and -independent pathways.
    J Biol Chem. 2003 Jul 18;278(29):27129-37 PMID: 12738791
  8. TRPV4 channel participates in receptor-operated calcium entry and ciliary beat frequency regulation in mouse airway epithelial cells.
    Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12611-6 PMID: 18719094
  9. A yeast genetic screen reveals a critical role for the pore helix domain in TRP channel gating.
    Neuron. 2008 May 8;58(3):362-73 PMID: 18466747
  10. Renal osteodystrophy.
    N Engl J Med. 1995 Jul 20;333(3):166-74 PMID: 7791820
  11. Metatropic dysplasia and its variants (analysis of 14 cases).
    Australas Radiol. 1988 Aug;32(3):325-37 PMID: 3202745
  12. N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I.
    J Pharmacol Exp Ther. 2008 Aug;326(2):432-42 PMID: 18499743
  13. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels.
    Nature. 2003 Jul 24;424(6947):434-8 PMID: 12879072
  14. Functional interaction of the cation channel transient receptor potential vanilloid 4 (TRPV4) and actin in volume regulation.
    Eur J Cell Biol. 2009 Mar;88(3):141-52 PMID: 19027987
  15. Modulation of TRPV4 gating by intra- and extracellular Ca2+.
    Cell Calcium. 2003 May-Jun;33(5-6):489-95 PMID: 12765694
  16. A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia.
    Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14034-9 PMID: 19666518
  17. Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia.
    Nat Genet. 2008 Aug;40(8):999-1003 PMID: 18587396
  18. A helix-breaking mutation in TRPML3 leads to constitutive activity underlying deafness in the varitint-waddler mouse.
    Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19583-8 PMID: 18048323
  19. Brachyolmia: radiographic and genetic evidence of heterogeneity.
    Am J Med Genet. 1989 Jun;33(2):209-19 PMID: 2669482
  20. Molecular mechanisms of TRPV4-mediated neural signaling.
    Ann N Y Acad Sci. 2008 Nov;1144:42-52 PMID: 19076362
  21. Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C.
    Nat Genet. 2010 Feb;42(2):170-4 PMID: 20037586
  22. Tyrosine phosphorylation modulates the activity of TRPV4 in response to defined stimuli.
    J Biol Chem. 2009 Jan 30;284(5):2923-2933 PMID: 19033444
  23. Activation of the TRPV4 ion channel is enhanced by phosphorylation.
    J Biol Chem. 2009 Oct 9;284(41):27884-27891 PMID: 19661060
  24. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C.
    Nat Genet. 2010 Feb;42(2):160-4 PMID: 20037588
  25. Yeast gain-of-function mutations reveal structure-function relationships conserved among different subfamilies of transient receptor potential channels.
    Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19607-12 PMID: 18042709
  26. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor.
    Cell. 2000 Oct 27;103(3):525-35 PMID: 11081638
  27. Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia.
    Am J Med Genet A. 2010 May;152A(5):1169-77 PMID: 20425821
  28. Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease.
    Hum Mol Genet. 2009 Jun 1;18(11):2053-62 PMID: 19279160
  29. Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia.
    Am J Hum Genet. 2009 Mar;84(3):307-15 PMID: 19232556
  30. TRPV4-pathy, a novel channelopathy affecting diverse systems.
    J Hum Genet. 2010 Jul;55(7):400-2 PMID: 20505684
  31. Chondroprotective role of the osmotically sensitive ion channel transient receptor potential vanilloid 4: age- and sex-dependent progression of osteoarthritis in Trpv4-deficient mice.
    Arthritis Rheum. 2010 Oct;62(10):2973-83 PMID: 20583100
  32. IP3 receptor binds to and sensitizes TRPV4 channel to osmotic stimuli via a calmodulin-binding site.
    J Biol Chem. 2008 Nov 14;283(46):31284-8 PMID: 18826956
  33. IP3 sensitizes TRPV4 channel to the mechano- and osmotransducing messenger 5'-6'-epoxyeicosatrienoic acid.
    J Cell Biol. 2008 Apr 7;181(1):143-55 PMID: 18378772
  34. Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives.
    J Biol Chem. 2002 Apr 19;277(16):13569-77 PMID: 11827975
  35. Spondylo-epiphyseal dysplasia, Maroteaux type (pseudo-Morquio syndrome type 2), and parastremmatic dysplasia are caused by TRPV4 mutations.
    Am J Med Genet A. 2010 Jun;152A(6):1443-9 PMID: 20503319
  36. TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin-to-integrin signaling.
    Circ Res. 2009 May 8;104(9):1123-30 PMID: 19359599
  37. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4.
    Nat Genet. 2010 Feb;42(2):165-9 PMID: 20037587
  38. Ca2+-dependent potentiation of the nonselective cation channel TRPV4 is mediated by a C-terminal calmodulin binding site.
    J Biol Chem. 2003 Jul 18;278(29):26541-9 PMID: 12724311
  39. Interdomain interactions control Ca2+-dependent potentiation in the cation channel TRPV4.
    PLoS One. 2010 May 11;5(5):e10580 PMID: 20485495
  40. Modulation of transient receptor potential Vanilloid 4-mediated membrane currents and synaptic transmission by protein kinase C.
    Mol Pain. 2009 Feb 10;5:5 PMID: 19208258
  41. Wild-type and brachyolmia-causing mutant TRPV4 channels respond directly to stretch force.
    J Biol Chem. 2010 Aug 27;285(35):27176-27181 PMID: 20605796
  42. Global comparative transcriptome analysis of cartilage formation in vivo.
    BMC Dev Biol. 2009 Mar 10;9:20 PMID: 19272164
  43. Revisiting metatropic dysplasia: presentation of a series of 19 novel patients and review of the literature.
    Am J Med Genet A. 2008 Apr 15;146A(8):992-6 PMID: 18348257
  44. Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4.
    Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):396-401 PMID: 14691263
  45. Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia family.
    J Med Genet. 2010 Oct;47(10):704-9 PMID: 20577006
  46. Functional gene screening system identified TRPV4 as a regulator of chondrogenic differentiation.
    J Biol Chem. 2007 Nov 2;282(44):32158-67 PMID: 17804410
  47. Activating mutation in a mucolipin transient receptor potential channel leads to melanocyte loss in varitint-waddler mice.
    Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18321-6 PMID: 17989217
  48. Bone remodeling during fracture repair: The cellular picture.
    Semin Cell Dev Biol. 2008 Oct;19(5):459-66 PMID: 18692584
  49. Forward genetic analysis reveals multiple gating mechanisms of TRPV4.
    J Biol Chem. 2010 Jun 25;285(26):19884-90 PMID: 20424166
  50. Bisandrographolide from Andrographis paniculata activates TRPV4 channels.
    J Biol Chem. 2006 Oct 6;281(40):29897-904 PMID: 16899456
  51. Modulation of the transient receptor potential vanilloid channel TRPV4 by 4alpha-phorbol esters: a structure-activity study.
    J Med Chem. 2009 May 14;52(9):2933-9 PMID: 19361196
  52. Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells.
    J Biol Chem. 2002 Dec 6;277(49):47044-51 PMID: 12354759
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2011-05-05
Epub
2011-00-05
Pages
e19533
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC3088684
Subset
IM
Grants
NIGMS NIH HHS · GM047856 · United States
NIGMS NIH HHS · GM054867 · United States
NIGMS NIH HHS · R01 GM047856 · United States
NINDS NIH HHS · NS067360 · United States
NINDS NIH HHS · R03 NS067360 · United States
NIGMS NIH HHS · R01 GM054867 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com